Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Page 4 of 12

Page 4 of 12 – SEC Filing

CUSIP
No.      761299106                

  1. 

NAME OF
REPORTING PERSONS:

Matthew Sirovich

  2.

CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

  3.

SEC USE ONLY

  4.

CITIZENSHIP OR PLACE OF
ORGANIZATION

United States

NUMBER OF SHARES
BENEFICIALLY OWNED BY EACH REPORTING PERSON

WITH

5. 

SOLE VOTING POWER

8,750

6.

SHARED VOTING POWER

3,811,821

7.

SOLE DISPOSITIVE POWER

8,750

8.

SHARED DISPOSITIVE POWER

3,811,821

  9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,820,571

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

¨

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (9)

10.4%

12.

TYPE OF REPORTING PERSON (SEE
INSTRUCTIONS)

IN, HC

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 4 of 12